What drugs does PRASCO make?

PRASCO has 6 FDA-approved drugs.

What therapeutic areas does PRASCO focus on?

PRASCO focuses primarily on Oncology and Respiratory and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

PRASCO

OncologyRespiratoryDermatology

Generics

PRASCO is a generic drug manufacturer focused on Oncology, Respiratory, Dermatology.

1971

Since

Drugs

Trials

125

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10

Labeling

MIRTAZAPINE 2026-02-02

FLUPHENAZINE HYDROCHLORIDE 2025-11-18

DEXTROAMPHETAMINE SULFATE 2025-10-28

Manufacturing (CMC)

MIRTAZAPINE 2025-10-02

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%

1 drugs

Respiratory 33%

1 drugs

Dermatology 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Oncology, Dermatology

Novartis big-pharma

Oncology, Respiratory

Baxter specialty

Oncology, Dermatology

OTSUKA big-pharma

Dermatology, Oncology, Respiratory

GSK big-pharma

Respiratory, Oncology

PRASCO

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (6)

Active (3)

Discontinued (3)

Company Info